Antalgic Effects of Well-being Treatments in Cancer Care
Well Being
1 other identifier
observational
180
1 country
1
Brief Summary
observational , Monocentric, study to assess antalgic effects of well-being treatment in cancer care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedFirst Submitted
Initial submission to the registry
July 6, 2022
CompletedFirst Posted
Study publicly available on registry
August 9, 2022
CompletedSeptember 8, 2025
September 1, 2025
1.7 years
July 6, 2022
September 5, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Pain assesment
numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."
1 immediately before well being treatment
Pain assesment
numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."
1 immediately after well being treatment
Eligibility Criteria
patients treated for a cancer in CH Valence, agree to participate on one of the 4 Well being treatments: foot reflexology, socio-aesthetics, sophrology and singing
You may qualify if:
- all type of cancer treated at the general Hospital of Valence
- patient agree to participate on Well being session: foot reflexology, socio-aesthetics, Sophrology and singing
- Age ≥ 18 years
- Affiliation to a Social security system
- Patient who has given written consent signed before any specific procedure of the protocol
You may not qualify if:
- Patient under guardianship, deprived of liberty, safeguard of justice
- Patient presenting a serious psychiatric pathology that does not allow compliance with the completion of the scale (at the discretion of the investigator)
- Refusal to participate in research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ch Valence
Valence, Drome, 26953, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2022
First Posted
August 9, 2022
Study Start
January 22, 2020
Primary Completion
September 30, 2021
Study Completion
December 30, 2021
Last Updated
September 8, 2025
Record last verified: 2025-09